Martinsried/Munich and Montréal, 10 April 2021. Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical stage immuno-oncology company focusing on the development of T cell immunotherapies, today presents the screening and identification of novel immunogenic tumor-specific antigens (TSAs) derived from non-coding regions of the human genome at the American Association for Cancer Research Virtual Annual Meeting (AACR) 2021. The […]
MONTREAL, April 6, 2021 /CNW Telbec/ – Ovarian cancer is the 5th most common cancer among women, as well as one of the most fatal. It is estimated that 3,100 Canadian women will be diagnosed each year, and 55 per cent of them will not live beyond five years from their diagnosis.* To address these alarming statistics, IRICoR and Ovarian Cancer Canada joined forces […]
IRICoR, Université de Montréal, IRIC and Valence Discovery collaborate to design novel drug candidates for the treatment of levodopa-induced dyskinesia in Parkinson’s disease patients
A leading researcher at Université de Montréal will leverage IRICoR’s expertise in accelerating drug discovery projects and Valence’s AI-enabled platform to design highly selective drug candidates against a newly identified target.
MONTREAL and CAMBRIDGE, Mass., March 10, 2021 […]
IRICoR will attend the AUTM Annual Meeting, March 15-18, 2021.
AUTM’s Annual Meeting invites technology transfer professionals from around the globe to network, make deals and gain valuable insights from world-class speakers and panels.
If you would like to meet with IRICoR at AUTM 2021, please contact Jean-louis Brochu, M.Sc., Senior Intellectual Property Manager, who will represent IRICoR at this event:
By email : […]
Montreal, March 08, 2021 – On the occasion of International Women’s Day, Nadine Beauger, President and CEO of IRICoR was invited to participate in a most relevant panel discussion bringing together renowned female leaders from the ecosystem life sciences. BIOQuébec joined forces with Women In Bio and MassBio to present this panel.
The event, […]
Alberta-based Applied Pharmaceutical Innovation has partnered with IRICoR, a Quebec-based Centre of Excellence in Commercialization and Research specialized in drug discovery, to expand drug discovery, development, and commercialization opportunities in Canada.
IRICoR’s expertise in de-risking early-stage novel therapies, combined with API’s expertise in translational science and later-stage development will help accelerate the commercialization of life-saving treatments for patients across the country. […]
On February 11, 2021, the Networks-Internship event took place. This speed dating activity (consisting of 10-minute meetings) aims to unite 1st and 2nd year students of the Bachelor of Biopharmaceutical Sciences (BSBP) with professionals in this industry.
The event allowed 90 students to have access to more than 40 professionals. BSBP students sent invitations to professionals they wished to meet in […]
Congratulations to the recipients of the 4th edition of Scholarship Competition – Entrepreneurship in Oncology (CEO)
IRICoR is very proud to announce the recipients of their 4th edition of Scholarship Competition – Entrepreneurship in Oncology (CEO).
This initiative offers the next generation of scientists an opportunity to take part in the Life Sciences Entrepreneurship Development Program initiated by a partnership between Montréal InVivo, the Faculté de pharmacie de l’Université […]
Montreal, February 11, 2021 – On this United Nations International Day of Women and Girls in Science, IRICoR is proud to honor all the great women who make up its team and to remind that women and girls play a role essential in the scientific community.
In addition, come and listen to 6 women, including our President and CEO, Nadine Beauger, […]